Gentherm to Participate in the J.P. Morgan Auto Conference

NORTHVILLE, Mich., July 19, 2018 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ: THRM), the global market leader and developer of innovative thermal management technologies, today announced that Phil Eyler, President and CEO, will present at the J.P. Morgan 2018 Auto Conference in New York City on Wednesday, August 8, 2018.  The presentation will begin at 10:10 a.m. (ET) and last for approximately 35 minutes.

There will be a live audio webcast of the presentation and a replay will be available for 45 days following the presentation on the Events page of the Investor Relations section of Gentherm’s website at: www.gentherm.com.  

Investor Contact Yijing Brentano [email protected]  248.308.1702

Media Contact Melissa Fischer [email protected]  248.289.9702

About Gentherm Gentherm (NASDAQ: THRM) is a global developer and marketer of innovative thermal management technologies for a broad range of heating and cooling and temperature control applications. Automotive products include variable temperature Climate Control Seats, heated automotive interior systems (including heated seats, steering wheels, armrests and other components), battery thermal management systems, cable systems and other electronic devices. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has over 13,000 employees in facilities in the United States, Germany, Canada, China, Hungary, Japan, Korea, Macedonia, Malta, Mexico, United Kingdom, Ukraine, and Vietnam.  For more information, go to www.gentherm.com.

You May Also Be Interested In

• Michael Wiese Launches New Engineering Scholarship to Foster Industry Innovation
• HelloNation Article Examines When Refinancing a Car Loan May Make Sense, Featuring Financial Expert Brad Bailey
• Neutra Corp’s Subsidiary Neutra Life Sciences Executes New Women’s Health Joint Venture and Expands Trial Portfolio